NEU.AX

Neuren Pharmaceuticals Limited

ASXAUDEQUITY DELAYED

22.46

▼ 0.68 (2.94%)

MARKET · —

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw

Open

22.90

Prev close

23.14

Day high

23.20

Day low

22.26

Volume

550.34K

Market cap

—

P/E (TTM)

—

52W range

11.00 – 23.76

Trailing performance

Price return · vs SPY

Returnvs SPY

-4.22% -2.9%

+36.45% +32.7%

+54.90% +51.8%

+78.25% +67.2%

YTD

+20.69% +8.4%

+27.18% +7.2%

+76.99% +2.8%

+925.57% —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on NEU.AX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Create free account Sign in

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Financial statements

As reported · 5 years · 2 quarters

Blank means not reported, not zero

Line item	2025	2024	2023	2022	2021	YoY
Total revenue	$64.63M	$213.24M	$231.93M	$14.55M	—	-69.7%
Operating revenue	$64.63M	$213.24M	$231.93M	$14.55M	—	-69.7%
Gross profit	$64.63M	$213.24M	$231.93M	$14.55M	—	-69.7%
Research & development	$36.39M	$32.97M	$26.75M	$12.71M	—	+10.4%
Selling, general & admin	$6.22M	$4.70M	$5.95M	$3.44M	—	+32.3%
Total operating expense	$42.63M	$37.69M	$32.71M	$16.16M	—	+13.1%
Operating income	$22.00M	$175.55M	$199.21M	-$1.61M	—	-87.5%
Net interest income	$12.16M	$11.01M	$5.69M	$391.00K	—	+10.4%
Pre-tax income	$38.93M	$182.94M	$205.14M	$184.00K	—	-78.7%
Tax provision	$8.49M	$40.90M	$48.06M	$0	—	-79.2%
Net income	$30.44M	$142.04M	$157.08M	$184.00K	—	-78.6%
Net income to common	$30.44M	$142.04M	$157.08M	$184.00K	—	-78.6%
Basic EPS	0.24	—	1.24	0.00	-0.07	—
Diluted EPS	0.23	1.09	1.20	0.00	—	-78.6%
EBIT	$22.00M	$175.55M	$199.21M	-$1.61M	—	-87.5%
EBITDA	$22.02M	$175.57M	$199.23M	-$1.60M	—	-87.5%
Basic shares	128.24M	127.77M	127.07M	125.97M	—	+0.4%
Diluted shares	130.80M	—	130.79M	125.97M	117.77M	—

Line item

2025

2024

2023

2022

2021

YoY

Total revenue

$64.63M

$213.24M

$231.93M

$14.55M

—

-69.7%

Operating revenue

$64.63M

$213.24M

$231.93M

$14.55M

—

-69.7%

Gross profit

$64.63M

$213.24M

$231.93M

$14.55M

—

-69.7%

Research & development

$36.39M

$32.97M

$26.75M

$12.71M

—

+10.4%

Selling, general & admin

$6.22M

$4.70M

$5.95M

$3.44M

—

+32.3%

Total operating expense

$42.63M

$37.69M

$32.71M

$16.16M

—

+13.1%

Operating income

$22.00M

$175.55M

$199.21M

-$1.61M

—

-87.5%

Net interest income

$12.16M

$11.01M

$5.69M

$391.00K

—

+10.4%

Pre-tax income

$38.93M

$182.94M

$205.14M

$184.00K

—

-78.7%

Tax provision

$8.49M

$40.90M

$48.06M

—

-79.2%

Net income

$30.44M

$142.04M

$157.08M

$184.00K

—

-78.6%

Net income to common

$30.44M

$142.04M

$157.08M

$184.00K

—

-78.6%

Basic EPS

0.24

—

1.24

0.00

-0.07

—

Diluted EPS

0.23

1.09

1.20

0.00

—

-78.6%

EBIT

$22.00M

$175.55M

$199.21M

-$1.61M

—

-87.5%

EBITDA

$22.02M

$175.57M

$199.23M

-$1.60M

—

-87.5%

Basic shares

128.24M

127.77M

127.07M

125.97M

—

+0.4%

Diluted shares

130.80M

—

130.79M

125.97M

117.77M

—

Line item	2025	2024	2023	2022	2021	YoY
Cash & equivalents	$4.23M	$3.15M	$17.09M	$40.18M	—	+34.1%
Cash & short-term investments	$296.12M	$222.24M	$228.54M	$40.18M	—	+33.2%
Accounts receivable	$450.00K	$155.15M	—	—	$7.00K	-99.7%
Total current assets	$332.23M	$399.33M	$247.16M	$43.25M	—	-16.8%
Property, plant & equipment	$45.00K	$31.00K	$43.00K	$21.00K	—	+45.2%
Total assets	$342.86M	$409.71M	$247.97M	$43.27M	—	-16.3%
Total current liabilities	$4.34M	$45.76M	$42.76M	$1.68M	—	-90.5%
Total liabilities	$4.41M	$45.80M	$42.76M	$1.68M	—	-90.4%
Retained earnings	$210.87M	$180.43M	$38.39M	-$118.69M	—	+16.9%
Shareholder equity	$338.45M	$363.90M	$205.21M	$41.59M	—	-7.0%
Working capital	$327.90M	$353.57M	$204.39M	$41.57M	—	-7.3%
Net tangible assets	$338.45M	$363.90M	$205.21M	$41.59M	—	-7.0%
Shares issued	126.64M	129.26M	129.67M	128.97M	—	-2.0%

Line item

2025

2024

2023

2022

2021

YoY

Cash & equivalents

$4.23M

$3.15M

$17.09M

$40.18M

—

+34.1%

Cash & short-term investments

$296.12M

$222.24M

$228.54M

$40.18M

—

+33.2%

Accounts receivable

$450.00K

$155.15M

—

$7.00K

-99.7%

Total current assets

$332.23M

$399.33M

$247.16M

$43.25M

—

-16.8%

Property, plant & equipment

$45.00K

$31.00K

$43.00K

$21.00K

—

+45.2%

Total assets

$342.86M

$409.71M

$247.97M

$43.27M

—

-16.3%

Total current liabilities

$4.34M

$45.76M

$42.76M

$1.68M

—

-90.5%

Total liabilities

$4.41M

$45.80M

$42.76M

$1.68M

—

-90.4%

Retained earnings

$210.87M

$180.43M

$38.39M

-$118.69M

—

+16.9%

Shareholder equity

$338.45M

$363.90M

$205.21M

$41.59M

—

-7.0%

Working capital

$327.90M

$353.57M

$204.39M

$41.57M

—

-7.3%

Net tangible assets

$338.45M

$363.90M

$205.21M

$41.59M

—

-7.0%

Shares issued

126.64M

129.26M

129.67M

128.97M

—

-2.0%

Line item	2025	2024	2023	2022	YoY
Capital expenditure	-$37.00K	-$10.00K	-$40.00K	-$19.00K	-270.0%
Investing cash flow	-$88.01M	$4.13M	-$211.49M	-$19.00K	-2,228.9%
Share buybacks	-$39.61M	-$10.44M	-$18.00K	-$2.00K	-279.6%
Financing cash flow	-$33.22M	-$8.78M	$3.62M	-$2.00K	-278.6%
Free cash flow	$125.39M	-$11.28M	$184.88M	$3.58M	+1,211.6%
End cash position	$4.23M	$3.15M	$17.09M	$40.18M	+34.1%

Line item

2025

2024

2023

2022

YoY

Capital expenditure

-$37.00K

-$10.00K

-$40.00K

-$19.00K

-270.0%

Investing cash flow

-$88.01M

$4.13M

-$211.49M

-$19.00K

-2,228.9%

Share buybacks

-$39.61M

-$10.44M

-$18.00K

-$2.00K

-279.6%

Financing cash flow

-$33.22M

-$8.78M

$3.62M

-$2.00K

-278.6%

Free cash flow

$125.39M

-$11.28M

$184.88M

$3.58M

+1,211.6%

End cash position

$4.23M

$3.15M

$17.09M

$40.18M

+34.1%

Line item	2025-12-31	2024-12-31	YoY
Cash & equivalents	$4.23M	$3.15M	+34.1%
Cash & short-term investments	$296.12M	$222.24M	+33.2%
Accounts receivable	$450.00K	$155.15M	-99.7%
Total current assets	$332.23M	$399.33M	-16.8%
Property, plant & equipment	$45.00K	$31.00K	+45.2%
Total assets	$342.86M	$409.71M	-16.3%
Total current liabilities	$4.34M	$45.76M	-90.5%
Total liabilities	$4.41M	$45.80M	-90.4%
Retained earnings	$210.87M	$180.43M	+16.9%
Shareholder equity	$338.45M	$363.90M	-7.0%
Working capital	$327.90M	$353.57M	-7.3%
Net tangible assets	$338.45M	$363.90M	-7.0%
Shares issued	126.64M	129.26M	-2.0%

Line item

2025-12-31

2024-12-31

YoY

Cash & equivalents

$4.23M

$3.15M

+34.1%

Cash & short-term investments

$296.12M

$222.24M

+33.2%

Accounts receivable

$450.00K

$155.15M

-99.7%

Total current assets

$332.23M

$399.33M

-16.8%

Property, plant & equipment

$45.00K

$31.00K

+45.2%

Total assets

$342.86M

$409.71M

-16.3%

Total current liabilities

$4.34M

$45.76M

-90.5%

Total liabilities

$4.41M

$45.80M

-90.4%

Retained earnings

$210.87M

$180.43M

+16.9%

Shareholder equity

$338.45M

$363.90M

-7.0%

Working capital

$327.90M

$353.57M

-7.3%

Net tangible assets

$338.45M

$363.90M

-7.0%

Shares issued

126.64M

129.26M

-2.0%

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

23.14

-2.94% from price

SMA 20

21.04

+6.73% from price

SMA 50

17.72

+26.73% from price

SMA 100

15.31

+46.70% from price

SMA 200

15.78

+42.35% from price

EMA 12

22.32

+0.61% from price

EMA 26

20.66

+8.73% from price

EMA 50

18.67

+20.30% from price

RSI (14)

66.5

Neutral

MACD (12,26,9)

1.67

Hist -0.07

ATR (14)

1.01

4.50% of price

Realised vol 30D

54.4%

Annualised

Bollinger upper

26.19

20, 2σ

Bollinger lower

15.89

20, 2σ

50 / 200 cross

Golden

17.72 vs 15.78

Trend bias

Above 200

+42.35%

Options chain

Account required

ExpirySpot 22.46

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.39

Less volatile than market

Correlation to SPY

0.08

Largely independent

Realised vol 30D

54.4%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-48.7%

Peak to trough

Max drawdown 5Y

-65.3%

Peak to trough

ATR 14

1.01

4.50% of price

Beta (reported)

—

5Y monthly, from filing

Headlines

NEU.AX · links out to the publisher

South Korean survivor fights for workplace harassment 'justice' AFP · 12m ago Messi scores but Miami slump continues with loss to Toronto AFP · 13m ago Josh Johnson's best plays from 2-TD game vs. Bears Preseason Week 2 NFL Highlights · 18m ago Sydney marathon unveils medal with wrong stadium AFP · 23m ago Prince Harry: royal misfit making unlikely UK return AFP · 25m ago Sandisk (SNDK) Stock Sees Fair Value Lift After Investor Day And Earnings Simply Wall St. · 27m ago Alaska Air Group (ALK) Following CEO Buying And New Routes Has Value Back In Focus Simply Wall St. · 27m ago iQIYI (IQ) Could Be 31% Undervalued Following Weak Earnings Simply Wall St. · 27m ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.